Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022
Mon, December 19, 2022
Fri, December 16, 2022

Raghuram Selvaraju Maintained (VRNA) at Strong Buy with Increased Target to $32 on, Dec 21st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-32-on-dec-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $30 to $32 on, Dec 21st, 2022.

Raghuram has made no other calls on VRNA in the last 4 months.



There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, December 20th, 2022
  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $26 on, Tuesday, December 20th, 2022
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $31 on, Friday, August 26th, 2022

Publication Contributing Sources